Results 71 to 80 of about 2,461 (207)

Effects of intracameral tissue plasminogen activator injection on posterior capsular opacification, fibrin formation, and intraocular pressure in dogs after phacoemulsification

Veterinary Ophthalmology, Volume 28, Issue 6, Page 917-925, November 2025.
Abstract Objective To evaluate whether intracameral tissue plasminogen activator (tPA) injection is effective in regulating posterior capsular opacification (PCO), fibrin formation and intraocular pressure (IOP) after cataract surgery. Animal Studied Prospective study involving 30 eyes of 21 dogs that underwent phacoemulsification.
Kyulee Kim, Young‐Sun Kang, Joon Young Kim   +2 more
wiley   +1 more source

Post‐Trabeculectomy Refractory Shallow Anterior Chamber: A Case Highlighting Overlooked Patient Behavior

Clinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT A shallow anterior chamber (AC) after glaucoma filtration surgery is a common early postoperative complication that can be vision‐threatening. So, early recognition of the causative factors and prompt management are necessary to avoid such devastating complications after surgery.
Md. Iftekher Iqbal, Fariah Osman
wiley   +1 more source

Comparison of Efficacy and Willingness to a 5% Gluconolactone‐Based Topical Serum and Intense Pulsed Light in Mild Erythema of Rosacea: A Paired Control Study

Journal of Cosmetic Dermatology, Volume 24, Issue 3, March 2025.
ABSTRACT Introduction Mild erythema is a common affliction of rosacea. Many methods including drugs and phototherapy (e.g., Intense Pulse Light, IPL) have been tried to alleviate symptoms. Topical applications for enhancing moisturization have also been thought to be of some benefit.
Yiran Peng, Mengping Mao, Ziyang Huang, Huimin Zhao, Ying Li, Dan Jian   +5 more
wiley   +1 more source

Iatrogenic Blepharoptosis: Multimodal Management and Treatment Technique With Botulinum Toxin Type A

Dermatology Research and Practice, Volume 2025, Issue 1, 2025.
Blepharoptosis as an Aesthetic Complication Eyelid ptosis, or blepharoptosis, following esthetic treatment of the upper third with botulinum toxin Type A (BoNT‐A) is a complication with a variable incidence depending on the injector’s experience. Among unexperienced injectors, it ranges from 2.5% to 5.4% and approximately 0.51% to 1% in experienced ...
Rengifo-Palacios Jaime Alberto, Macías-Arias Paola Andrea, Uribe-Posada Maria Paulina, Lopera-Botero Luisa, Tulika Banerjee   +4 more
wiley   +1 more source

Analytical method development and validation for the determination of Brinzolamide by RP-HPLC [PDF]

, 2020
Brinzolamide is inhibitor of carbonic anhydride and is highly specific and non-competitive. The aim of the present study is to develop a simple, precise, accurate, sensitive RP-HPLC method for the determination of bulk drug.
Kulkarni, Amol, Shirsat, Mrunal K., Tiwari, Balakrishna   +2 more
core   +2 more sources

A Systematic Review of Ocular Complications Following Different Types of Covid‐19 Vaccines

Journal of Immunology Research, Volume 2025, Issue 1, 2025.
Introduction More than 6 million deaths from the novel coronavirus, the Coronavirus disease 2019 (COVID‐19) infection, have prompted the development of several prophylactic vaccines of COVID‐19. This systematic review summarizes the ocular complications of various COVID‐19 vaccinations, diseases diagnosed, treatment, and risk factors.
Bahareh Ebrahimi, Hossein Kargar Jahromi, Nazanin Shafiei Jahromi, Mina Molayem, Poorani Gurumallesh   +4 more
wiley   +1 more source

Approaches in topical ocular drug delivery and developments in the use of contact lenses as drug-delivery devices [PDF]

, 2017
The file attached to this record is the author's final peer reviewed version. The Publisher's final version can be found by following the DOI link.Drug-delivery approaches have diversified over the last two decades with the emergence of nanotechnologies,
Acheampong A, Bar-Ilan A, Do MP, Forrester JV, Gasmi H, Giannaccare G, Lin MC, Nijhawan R, Patel PB, Pratt NL, Schaeffer HE, Schopf LR, Smolin G, Song HB, Waltman SR, Wei J, Wheeler J, Xu X   +17 more
core   +2 more sources

Tools for clinical pharmacists to identify medications that can cause drug‐induced cognitive impairment: A systematic review

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 7, Issue 12, Page 1207-1227, December 2024.
Abstract Cognitive impairment affects around 19% of community‐dwelling older adults in the United States. Pharmacists can play a significant role in identifying and deprescribing cognitive‐impairing medications through cognitive‐focused medication reviews or as part of comprehensive medication management.
Jacob Stanton, Michael R. Gionfriddo, Gail B. Rattinger, Yuan Fang, Mia E. Lussier   +4 more
wiley   +1 more source

Novel Uses of Brimonidine

Delhi Journal of Ophthalmology
Brimonidine tartrate is a third-generation, highly selective alpha 2 agonist currently available in various formulations and doses to treat ophthalmological conditions. The aim of this article was to review pharmacokinetics, mechanisms, side effects, and
Hikkalagutti. S. Kruthika, Chauhan Tulika, Patyal Sagarika, Bhardwaj Kanika, Dabas Garvita   +4 more
doaj   +1 more source

Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model [PDF]

, 2020
Intravitreal administration is widely used in ophthalmological practice to maintain therapeutic drug levels near the neuroretina and because drug delivery systems are necessary to avoid reinjections and sight-threatening side effects.
Rodrigo, M.J., Cardiel, M.J., Fraile, J.M., Mendez-Martinez, S., Martinez-Rincon, T., Subias, M., Polo, V., Ruberte, J., Ramirez, T., Vispe, E., Luna, C., Mayoral, J.A., Garcia-Martin, E.   +12 more
core   +2 more sources